Uvax Bio Appoints Kevin O'Neill as Interim Chief Executive Officer
Uvax Bio, LLC, ("Uvax” or "the Company”) a privately held, clinical-stage vaccine company utilizing rational and computational biology to design and deliver novel 1c-SApNP ® protein-based vaccines, today announced the appointment of Chief Business Officer Kevin O'Neill to Interim Chief Executive Officer (CEO).
One month into his new position, Stéphane de La Faverie, president and chief executive officer of the Estée Lauder Cos., is ...
Asian News International on MSN22h
Chris Dehring begins tenure as Chief Executive Officer of Cricket West IndiesCricket West Indies (CWI) officially welcomed Chris Dehring as he began his tenure as Chief Executive Officer (CEO) on Monday ...
Tracy Robinson says the railway has plans it will trigger in response to Trump’s threat to impose 25-per-cent tariffs on ...
Sony Group said Chief Operating Officer Hiroki Totoki would become chief executive on April 1.
Ghana-focused player confirmed appointment of Richard Miller on Tuesday as interim chief executive and chief financial ...
CONCORD, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Highly regarded executive, Germán Piderit, has joined Wyse Meter Solutions Inc. (“Wyse”) as Chief Operating Officer, effective January 27, 2025.
Ajit Mohan will be responsible for growing Snap's advertising business across all regions and leading the social media company's revenue product and business operations organisations ...
The council is set to select from in-house for its interim chief executive, the most senior officer role in the local ...
With Dehring taking up his new position, is in a critical position. The sport in the region has faced challenges in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback